NAPC Defense, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NAPC Defense, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Apr 30, 2023 | $85.0K | Aug 13, 2024 |
| FY2020 | Apr 30, 2019 | $14.2K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $15.2K | Aug 16, 2019 |
| FY2018 | Apr 30, 2017 | $0 | Aug 24, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Apr 30, 2023 | $85.0K | Aug 13, 2024 |
| FY2020 | Apr 30, 2019 | $14.2K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $15.2K | Aug 16, 2019 |
| FY2018 | Apr 30, 2017 | $0 | Aug 24, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($3.38M) | Sep 19, 2025 |
| FY2025 | Apr 30, 2024 | ($712.0K) | Sep 19, 2025 |
| FY2024 | Apr 30, 2023 | ($941.1K) | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | ($2.07M) | Sep 7, 2023 |
| FY2022 | Apr 30, 2021 | ($583.8K) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($592.2K) | Aug 13, 2021 |
| FY2020 | Apr 30, 2019 | ($48.6K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($39.5K) | Aug 16, 2019 |
| FY2018 | Apr 30, 2017 | ($814) | Aug 24, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($2.48M) | Sep 19, 2025 |
| FY2025 | Apr 30, 2024 | ($384.0K) | Sep 19, 2025 |
| FY2024 | Apr 30, 2023 | ($464.0K) | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | ($658.8K) | Sep 7, 2023 |
| FY2022 | Apr 30, 2021 | ($604.0K) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($592.2K) | Aug 13, 2021 |
| FY2020 | Apr 30, 2019 | ($48.6K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($39.5K) | Aug 16, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $15.6K | Sep 19, 2025 |
| FY2024 | Apr 30, 2023 | $8.3K | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | $8.0K | Sep 7, 2023 |
| FY2022 | Apr 30, 2021 | $20.0K | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $120.0K | Aug 13, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($797.2K) | Sep 19, 2025 |
| FY2025 | Apr 30, 2024 | ($340.7K) | Sep 19, 2025 |
| FY2024 | Apr 30, 2023 | ($424.1K) | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | ($613.8K) | Sep 7, 2023 |
| FY2022 | Apr 30, 2021 | ($368.9K) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($444.8K) | Aug 13, 2021 |
| FY2020 | Apr 30, 2019 | ($31.2K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($29.6K) | Aug 16, 2019 |
| FY2018 | Apr 30, 2017 | $0 | Aug 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Apr 30, 2020 | $60.4K | Aug 13, 2021 |
| FY2019 | Apr 30, 2018 | $21.1K | Aug 16, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $16.5K | Sep 19, 2025 |
| FY2025 | Apr 30, 2024 | $1.81M | Sep 19, 2025 |
| FY2024 | Apr 30, 2023 | $368.8K | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | $79.6K | Sep 7, 2023 |
| FY2022 | Apr 30, 2021 | $870.9K | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $790.7K | Aug 13, 2021 |
| FY2020 | Apr 30, 2019 | $0 | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $29.5K | Aug 16, 2019 |
| FY2018 | Apr 30, 2017 | $2.6K | Aug 24, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.16M | Sep 19, 2025 |
| FY2025 | Apr 30, 2024 | $1.05M | Sep 19, 2025 |
| FY2024 | Apr 30, 2023 | $1.17M | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | $950.6K | Sep 7, 2023 |
| FY2022 | Apr 30, 2021 | $105.9K | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $127.4K | Aug 13, 2021 |
| FY2020 | Apr 30, 2019 | $45.2K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $26.1K | Aug 16, 2019 |
| FY2018 | Apr 30, 2017 | $10.0K | Aug 24, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($1.15M) | Sep 19, 2025 |
| FY2025 | Apr 30, 2024 | $769.3K | Sep 19, 2025 |
| FY2025 | Apr 30, 2023 | ($799.1K) | Sep 19, 2025 |
| FY2024 | Apr 30, 2022 | ($870.9K) | Aug 13, 2024 |
| FY2023 | Apr 30, 2021 | $765.0K | Sep 7, 2023 |
| FY2022 | Apr 30, 2020 | $663.4K | Aug 15, 2022 |
| FY2021 | Apr 30, 2019 | ($45.2K) | Aug 13, 2021 |
| FY2020 | Apr 30, 2018 | $3.4K | Aug 13, 2020 |
| FY2019 | Apr 30, 2017 | $2.2K | Aug 16, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($8.45M) | Sep 19, 2025 |
| FY2025 | Apr 30, 2024 | ($4.99M) | Sep 19, 2025 |
| FY2024 | Apr 30, 2023 | ($4.28M) | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | ($3.33M) | Sep 7, 2023 |
| FY2022 | Apr 30, 2021 | ($1.26M) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($681.1K) | Aug 13, 2021 |
| FY2020 | Apr 30, 2019 | ($88.9K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($40.3K) | Aug 16, 2019 |
| FY2018 | Apr 30, 2017 | ($814) | Aug 24, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 30, 2018 | $7.3K | Aug 24, 2018 |
| FY2018 | Apr 30, 2017 | $7.4K | Aug 24, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 238.25M | Sep 19, 2025 |
| FY2025 | Apr 30, 2024 | 168.40M | Sep 19, 2025 |
| FY2024 | Apr 30, 2023 | 43.82M | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | 9.49M | Sep 7, 2023 |
| FY2022 | Apr 30, 2021 | 8.15M | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | 7.40M | Aug 13, 2021 |
| FY2020 | Apr 30, 2019 | 5.04M | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | 5.04M | Aug 16, 2019 |
| FY2018 | Apr 30, 2017 | 3.00M | Aug 24, 2018 |